Today, doctors are increasingly looking at the genetic makeup of each patient’s tumor to guide treatment decisions.
Correlating survival outcomes in patients with advanced prostate cancer with novel hyperpolarized 13C MRI metabolic imaging biomarkers. KRAS c.436G > A p.Ala146Thr ...